Blake Chancellor assists the firm in biotechnology patent prosecution. Blake has extensive knowledge in the areas of molecular biology, molecular neuroscience, and computational biology.
Blake’s experience spans neurodegenerative disease, glial biology, high-dimensional/large-scale data analysis, molecular biology and biochemistry techniques, in situ analyses, drug discovery, high-throughput chemical screening, stem cell biology, cell culture, and rodent behavior.
Prior to joining Wolf Greenfield, Blake received his PhD in Genetics and Genomics from Harvard University, with a focus on genomic analyses of human neurodegenerative tauopathies. As a graduate student researcher in the Department of Genetics at Harvard Medical School, he applied single-cell transcriptomic analyses to reveal the differential roles of individual brain cells in human white matter tissue to the pathology of Chronic Traumatic Encephalopathy and Alzheimer’s disease.